Drug Discovery 2022: driving the next life science revolution

Molecular Docking Studies, Synthesis and Biological Evaluation of Novel Heterocyclic Derivatives as a Potential ALK Inhibitors

This Presentation has not been released yet

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis